New Type 2 Drugs Change Treatment Decisions
Metformin, the cornerstone in treating type 2 diabetes, saw an increase in usage among type 2s from 23 percent of
Read more
Actos
Diabetes Patients on Insulin Sensitizers Run Lower PAD Risk
Insulin sensitizers–drugs that increase sensitivity to insulin such as Avandia and Actos–could help lessen the risk of peripheral arterial disease
Read more
FDA Panelists Vote to Ease Up on Avandia
A significant majority-20 of 26 members attending a combined meeting of FDA advisory committees-has voted to modify or remove the
Read more
US Sale of Generic Actos Gets FDA Nod
The Food and Drug Administration has approved US sale of generic pioglitazone (trade name Actos) for the treatment of type
Read more